Effect of D, L‐threo‐1‐phenyl‐2‐decanoylamino‐3‐morpholino‐1‐propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells

References

• Volm M, Kästel M, Mattern J, Efferth T. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer 1993;71:3981–7.
   PubMed Web of Science ®Google Scholar
• Lala P, Ito S, Lingwood CA. Retroviral transfection of Madin–Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of P-glycoprotein in glycolipid synthesis. J Biol Chem 2000;275:6246–51.
   PubMed Web of Science ®Google Scholar
• Reynolds CP, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 2004;206:169–80.
   PubMed Web of Science ®Google Scholar
• Uchida Y, Itoh M, Taguchi Y, Yamaoka S, Umehara H, Ichikawa S, et al.. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells. Cancer Res 2004;64:6271–9.
   PubMed Web of Science ®Google Scholar
• Gouazé V, Yu JY, Bleicher RJ, Han TY, Liu YY, Wang H, et al.. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther 2004;3:633–9.
   PubMed Web of Science ®Google Scholar
• Di Sano F, Di Bartolomeo S, Fazi B, Fiorentini C, Matarrese P, Spinedi A, et al.. Antisense to glucosylceramide synthase in human neuroepithelioma affects cell growth but not apoptosis. Cell Death Differ 2002;9:693–5.
   PubMed Web of Science ®Google Scholar
• Deng W, Li R, Guerrera M, Liu Y, Ladisch S. Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation. Glycobiology 2002;12:145–52.
   PubMed Web of Science ®Google Scholar
• Gouazé V, Liu YY, Prickett CS, Yu JY, Giuliano AE, Cabot MC. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res 2005;65:3861–7.
   PubMed Web of Science ®Google Scholar
• Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, et al.. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemother Pharmacol 2004;53:349–56.
   PubMed Web of Science ®Google Scholar
• Zhao QX, Chen BA, Cheng J, Ding JH, Gao F, Gao C, et al.. Effect of tetrandrine, Toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008;16:61–4.
   PubMedGoogle Scholar
• Shen H, Xu W, Chen Q, Wu Z, Tang H, Wang F. Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription. J Cancer Res Clin Oncol 2010;136:659–65.
   PubMed Web of Science ®Google Scholar
• Xu WL, Shen HL, Ao ZF, Chen BA, Xia W, Gao F, et al.. Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leuk Res 2006;30:407–13.
   PubMed Web of Science ®Google Scholar
• Lee L, Abe A, Shayman JA. Improved inhibitors of glucosylceramide synthase. J Biol Chem 1999;274:14662–9.
   PubMed Web of Science ®Google Scholar
• Sietsma H, Veldman RJ, Kolk D, Ausema B, Nijhof W, Kamps W, et al.. 1-phenyl-2-ecanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine. Clin Cancer Res 2000;6:942–8.
   PubMed Web of Science ®Google Scholar
• Deng W, Li R, Ladisch S. Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst 2000;92:912–7.
   PubMed Web of Science ®Google Scholar
• Senchenkov A, Litvak DA, Cabot MC. Targeting ceramide metabolism – a strategy for overcoming drug resistance. J Nat Cancer Inst 2001;93:347–57.
   PubMed Web of Science ®Google Scholar
• Inokuchi J, Jimbo M, Momosaki K, Shimeno H, Nagamatsu A, Radin NS. Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res 1990;50:6731–7.
   PubMed Web of Science ®Google Scholar
• Wang JQ, Chen BA, Cheng J, Xu WL, Sun XC. Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent resistance to adriamycin in human lukemia cell line K562/A02. Ai Zheng 2008;27:491–5.
   PubMedGoogle Scholar
• Liu YY, Han TY, Yu JY, Bitterman A, Le A, Giuliano AE, et al.. Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells. J Lipid Res 2004;45:933–40.
   PubMed Web of Science ®Google Scholar
• Weiss M, Hettmer S, Smith P, Ladisch S. Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase. Cancer Res 2003;63:3654–8.
   PubMed Web of Science ®Google Scholar
• Marie JP, Faussat-Suberville AM, Zhou D, Zittoun R. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. Leukemia 1993;7:825–31.
   PubMed Web of Science ®Google Scholar
• Guerci A, Merlin JL, Missoum N, Feldmann L, Marchal S, Witz F, et al.. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood 1995;85:2147–53.
   PubMed Web of Science ®Google Scholar
• Xie P, Shen YF, Shi YP, Ge SM, Gu ZH, Wang J, et al.. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res 2008;32:475–80.
   PubMed Web of Science ®Google Scholar
• Plo I, Lehne G, Beckstrøm KJ, Maestre N, Bettaïeb A, Laurent G, et al.. Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells. Mol Pharmacol 2002;62:304–12.
   PubMed Web of Science ®Google Scholar
• Halter D, Neumann S, van Dijk SM, Wolthoorn J, de Mazière AM, Vieira OV, et al.. Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis. J Cell Biol 2007;179:101–15.
   PubMed Web of Science ®Google Scholar
• Shabbits JA, Mayer LD. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs. Mol Cancer Ther 2002;1:205–13.
   PubMed Web of Science ®Google Scholar
• Turzanski J, Grundy M, Shang S, Russell N, Pallis M. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway. Exp Hematol 2005;33:62–72.
   PubMed Web of Science ®Google Scholar